Patients with influenza had higher rates of in-hospital mortality (6.2% vs. ... They called for increased emphasis on increasing influenza vaccination rates and developing vaccines that provide better protection.
A label change to note that Afluria influenza virus vaccine has been associated with an increased incidence of fever and febrile seizure among young children in Australia, mainly among those less ... Vaccines for the 2010-2011 influenza season in the
clinicians for influenza-like illness by state), as reported by the CDC and Prevention Surveillance Network. ... Influenza activity in the months before hospitalization was not associated with either outcome.
Seasonal influenza vaccine Fluarix was approved for children ages 3 years to 17 years. ... The vaccine, which contains inactivated influenza A and B viruses, had previously been approved for use in adults.
The influenza vaccine formulation for the 2012-2013 season has been approved, the FDA announced last week. ... Based on virus samples and global disease patterns, the strains selected for inclusion in the 2012-2013 flu vaccines are:.
single oral dose, is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. ... Safety and efficacy were tested in two randomized trials of 1, 832 patients who received the drug, a placebo, or
Unlike other available seasonal flu vaccines, FluBlok does not use the influenza virus or chicken eggs in its manufacturing process and can be used in adults with an egg allergy of ... FluBlok has a shorter shelf life than other influenza vaccines, so
Testing is not always necessary in all patients, especially in a community known to already be affected by influenza. ... clinical signs and symptoms of influenza,. prevalence of influenza in the population tested,.
Seroprotection rates after vaccination were higher in the high-dose group for three strains of flu: H1N1 (96% vs. ... 92%; treatment difference, 3 percentage points; 95% CI, 3 to 10 percentage points; P=0.32), and influenza B (91% vs.
or influenza and congestive heart failure.”.